LONA
LeonaBio, Inc.
Company overview
- Market capitalization
- $27.04M
- Employees
- 19
- Latest publication
- 2026-09-29
About LeonaBio, Inc.
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of diabetic neuropathy, which is in phase 1 clinical trial; and ATH-1017 for the treatment of Alzheimer's disease and Parkinson's disease, which is in phase 2 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 231,000USD | 68,088,000USD | 243,000USD | 200,000USD | 243,000USD | — | — | 242,000USD |
| Gross Profit | -231,000USD | -68,088,000USD | -243,000USD | -200,000USD | -243,000USD | — | — | -242,000USD |
| Research Development | 11,262,000USD | 6,712,000USD | 2,582,000USD | 3,661,000USD | 4,302,000USD | 9,370,000USD | 17,922,000USD | 21,912,000USD |
| Selling General Administrative | 6,881,000USD | 3,765,000USD | 4,049,000USD | 3,630,000USD | 5,234,000USD | 6,196,000USD | 7,572,000USD | 5,874,000USD |
| Total Operating Expenses | 17,912,000USD | 10,477,000USD | 6,631,000USD | 7,091,000USD | 9,293,000USD | 15,566,000USD | 29,621,000USD | 27,786,000USD |
| Operating Income | -18,143,000USD | -78,565,000USD | -6,874,000USD | -7,291,000USD | -9,536,000USD | -15,566,000USD | -29,621,000USD | -28,028,000USD |
| Income Before Tax | -32,948,000USD | -82,889,000USD | -6,611,000USD | -6,966,000USD | -9,143,000USD | -15,003,000USD | -28,741,000USD | -26,859,000USD |
| Net Income | -32,948,000USD | -82,889,000USD | -6,611,000USD | -6,966,000USD | -9,143,000USD | -15,003,000USD | -28,741,000USD | -26,859,000USD |
| Net Income From Continuing Ops | -32,948,000USD | -82,889,000USD | -6,611,000USD | -6,966,000USD | -9,143,000USD | -15,003,000USD | -28,741,000USD | — |
| Ebit | -18,143,000USD | -78,565,000USD | -6,611,000USD | -6,966,000USD | -9,143,000USD | -15,566,000USD | -25,494,000USD | -28,028,000USD |
| Ebitda | -17,912,000USD | -78,324,000USD | -6,503,000USD | -6,766,000USD | -8,900,000USD | -15,323,000USD | -25,251,000USD | -27,786,000USD |
| Depreciation And Amortization | 231,000USD | 241,000USD | 108,000USD | 200,000USD | 243,000USD | 243,000USD | 243,000USD | 242,000USD |
| Reconciled Depreciation | 231,000USD | 243,000USD | 243,000USD | 243,000USD | 243,000USD | 243,000USD | 243,000USD | — |
| Total Other Income Expense Net | -14,805,000USD | -4,324,000USD | 263,000USD | 325,000USD | 393,000USD | 563,000USD | 880,000USD | 1,169,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 4,127,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | — | — | — |
| Cost Of Revenue | 68,088,000USD | — | — | — | 479,000USD | 2,000,000USD | — | — |
| Gross Profit | -68,088,000USD | — | — | — | -479,000USD | -2,000,000USD | — | — |
| Research Development | 17,500,000USD | 70,682,000USD | 93,790,000USD | 61,464,000USD | 42,794,000USD | 13,286,000USD | 3,793,000USD | 3,589,000USD |
| Selling General Administrative | 16,678,000USD | 26,093,000USD | 33,304,000USD | 32,552,000USD | 21,228,000USD | 6,709,000USD | 1,656,000USD | 1,420,000USD |
| Total Operating Expenses | 34,178,000USD | 100,902,000USD | 125,466,000USD | 104,016,000USD | 63,543,000USD | 17,995,000USD | 4,695,000USD | 5,009,000USD |
| Operating Income | -102,266,000USD | -100,902,000USD | -125,466,000USD | -104,016,000USD | -64,022,000USD | -19,995,000USD | -5,449,000USD | -5,009,000USD |
| Income Before Tax | -105,609,000USD | -96,940,000USD | -117,672,000USD | -95,639,000USD | -54,853,000USD | -19,955,000USD | -5,161,000USD | -5,097,000USD |
| Net Income | -105,609,000USD | -96,940,000USD | -117,672,000USD | -95,639,000USD | -54,853,000USD | -19,955,000USD | -5,161,000USD | -5,097,000USD |
| Net Income From Continuing Ops | -105,609,000USD | -96,940,000USD | -117,672,000USD | -95,639,000USD | -54,853,000USD | — | — | — |
| Ebit | -102,266,000USD | -96,775,000USD | -126,937,000USD | -88,855,000USD | -54,850,000USD | -19,588,000USD | -4,815,000USD | -5,088,000USD |
| Ebitda | -101,623,000USD | -95,805,000USD | -125,968,000USD | -88,010,000USD | -54,371,000USD | -19,586,000USD | -4,813,000USD | -79,000USD |
| Depreciation And Amortization | 643,000USD | 970,000USD | 969,000USD | 845,000USD | 479,000USD | 2,000USD | 2,000USD | 5,009,000USD |
| Reconciled Depreciation | 972,000USD | 970,000USD | 969,000USD | 845,000USD | 479,000USD | — | — | — |
| Total Other Income Expense Net | -3,343,000USD | 3,962,000USD | 7,794,000USD | 8,377,000USD | 9,169,000USD | 40,000USD | 288,000USD | -88,000USD |
| Unclassified Operating Expenses | — | 4,127,000USD | -1,628,000USD | 10,000,000USD | — | -2,000,000USD | — | — |
| Interest Expense | — | — | — | 24,316,000USD | 3,000USD | 367,000USD | 346,000USD | 9,000USD |
| Interest Income | — | — | — | — | 337,000USD | — | — | — |
| Net Interest Income | — | — | — | — | 334,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 56,894,000USD | 71,590,000USD | 92,151,000USD | 30,033,000USD | 35,545,000USD | 43,513,000USD | 58,779,000USD | 86,246,000USD |
| Cash And Equivalents | 32,323,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 51,067,000USD | 67,679,000USD | 88,331,000USD | 25,226,000USD | 29,823,000USD | 36,670,000USD | 51,275,000USD | 68,856,000USD |
| Short Term Investments | 18,744,000USD | 34,846,000USD | 19,055,000USD | 4,352,000USD | 9,935,000USD | 10,248,000USD | 2,837,000USD | 0USD |
| Total Current Assets | 54,808,000USD | 69,202,000USD | 89,458,000USD | 27,025,000USD | 32,218,000USD | 39,853,000USD | 54,841,000USD | 82,002,000USD |
| Other Current Assets | 3,741,000USD | 1,523,000USD | 1,127,000USD | 1,799,000USD | 2,395,000USD | 3,183,000USD | 3,566,000USD | 11,518,000USD |
| Other Non Current Assets | 55,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 23,299,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 7,817,000USD | 6,666,000USD | 47,503,000USD | 2,787,000USD | 2,981,000USD | 5,492,000USD | 13,135,000USD | 27,751,000USD |
| Other Current Liabilities | 4,906,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 1,034,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 33,595,000USD | 49,303,000USD | 27,790,000USD | 26,786,000USD | 31,986,000USD | 37,330,000USD | 44,841,000USD | 57,583,000USD |
| Total Equity Including Noncontrolling Interest | 33,595,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,400,000USD | 1,702,000USD | 2,007,000USD | 2,322,000USD | 2,634,000USD | 2,944,000USD | 3,252,000USD | 3,558,000USD |
| Accounts Payable | 2,420,000USD | 1,764,000USD | 4,587,000USD | 266,000USD | 171,000USD | 867,000USD | 319,000USD | 388,000USD |
| Short Term Debt | 491,000USD | 478,000USD | 465,000USD | 452,000USD | 439,000USD | 426,000USD | 414,000USD | 402,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -563,710,000USD | -544,703,000USD | -511,755,000USD | -428,866,000USD | -422,255,000USD | -415,289,000USD | -406,146,000USD | -391,143,000USD |
| Accumulated Other Comprehensive Income | -9,000USD | -13,000USD | -4,000USD | -2,000USD | -3,000USD | -4,000USD | 1,000USD | 3,000USD |
| Total Liab | — | 22,287,000USD | 64,361,000USD | 3,247,000USD | 3,559,000USD | 6,183,000USD | 13,938,000USD | 28,663,000USD |
| Other Current Liab | — | 4,424,000USD | 42,451,000USD | 2,069,000USD | 2,371,000USD | 4,199,000USD | 12,402,000USD | 26,961,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Cash | — | 32,833,000USD | 69,276,000USD | 20,874,000USD | 19,888,000USD | 26,422,000USD | 48,438,000USD | 68,856,000USD |
| Net Debt | — | -32,142,000USD | -68,473,000USD | -19,962,000USD | -18,871,000USD | -25,305,000USD | -47,221,000USD | -67,542,000USD |
| Short Long Term Debt Total | — | 691,000USD | 803,000USD | 912,000USD | 1,017,000USD | 1,117,000USD | 1,217,000USD | 1,314,000USD |
| Property Plant Equipment Gross | — | 6,200,000USD | 6,274,000USD | 6,346,000USD | 6,415,000USD | 6,482,000USD | 6,547,000USD | 6,610,000USD |
| Common Stock Shares Outstanding | — | 4,275,762shares | 4,275,762shares | 3,943,887shares | 3,909,296shares | 3,904,245shares | 3,848,088shares | 3,851,760shares |
| Non Current Assets Total | — | 2,388,000USD | 2,693,000USD | 3,008,000USD | 3,327,000USD | 3,660,000USD | 3,938,000USD | 4,244,000USD |
| Non Current Liabilities Total | — | 15,621,000USD | 16,858,000USD | 459,999USD | 578,000USD | 691,000USD | 803,000USD | 912,000USD |
| Non Current Liabilities Other | — | 15,408,000USD | 16,520,000USD | — | — | — | — | — |
| Non Currrent Assets Other | — | 686,000USD | 686,000USD | 55,000USD | 62,000USD | 716,000USD | 686,000USD | 55,000USD |
| Net Working Capital | — | 62,536,000USD | 41,955,000USD | 24,238,000USD | 29,237,000USD | 34,361,000USD | 41,706,000USD | 54,251,000USD |
| Unclassified Equity | — | 594,017,000USD | 539,547,000USD | 455,646,000USD | 454,236,000USD | 452,615,000USD | 450,978,000USD | 448,715,000USD |
| Net Receivables | — | — | — | — | — | — | — | 1,628,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 92,151,000USD | 58,779,000USD | 160,245,000USD | 258,153,000USD | 332,008,000USD | 279,563,000USD | 2,189,000USD | 4,933,000USD |
| Other Current Assets | 1,127,000USD | 3,566,000USD | 5,682,000USD | 7,189,000USD | 4,704,000USD | 6,355,000USD | 97,000USD | 74,000USD |
| Total Liab | 64,361,000USD | 13,938,000USD | 30,057,000USD | 23,016,000USD | 10,924,000USD | 5,281,000USD | 21,912,000USD | 19,820,000USD |
| Total Stockholder Equity | 27,790,000USD | 44,841,000USD | 130,188,000USD | 235,137,000USD | 321,084,000USD | 274,282,000USD | -19,723,000USD | -14,887,000USD |
| Other Current Liab | 42,451,000USD | 12,402,000USD | 28,343,000USD | 18,604,000USD | 8,437,000USD | 3,123,000USD | 852,000USD | 451,000USD |
| Common Stock | 1,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | — | 3,000USD |
| Capital Stock | 1,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | — | — | — |
| Retained Earnings | -511,755,000USD | -406,146,000USD | -309,206,000USD | -191,534,000USD | -95,895,000USD | -41,042,000USD | -21,087,000USD | -15,926,000USD |
| Cash | 69,276,000USD | 48,438,000USD | 90,584,000USD | 95,966,000USD | 110,537,000USD | 60,625,000USD | 2,056,000USD | 3,317,000USD |
| Cash And Short Term Investments | 88,331,000USD | 51,275,000USD | 147,419,000USD | 200,344,000USD | 253,759,000USD | 184,682,000USD | 2,056,000USD | 4,817,000USD |
| Total Current Assets | 89,458,000USD | 54,841,000USD | 154,729,000USD | 207,533,000USD | 260,799,000USD | 192,337,000USD | 2,160,000USD | 4,897,000USD |
| Total Current Liabilities | 47,503,000USD | 13,135,000USD | 28,840,000USD | 21,431,000USD | 9,292,000USD | 4,405,000USD | 1,273,000USD | 572,000USD |
| Net Debt | -68,473,000USD | -47,221,000USD | -88,999,000USD | -94,055,000USD | -108,617,000USD | -59,625,000USD | -503,000USD | -2,595,000USD |
| Short Term Debt | 465,000USD | 414,000USD | 368,000USD | 326,000USD | 288,000USD | 124,000USD | — | — |
| Short Long Term Debt Total | 803,000USD | 1,217,000USD | 1,585,000USD | 1,911,000USD | 1,920,000USD | 1,000,000USD | 1,553,000USD | 722,000USD |
| Short Term Investments | 19,055,000USD | 2,837,000USD | 56,835,000USD | 104,378,000USD | 143,222,000USD | 124,057,000USD | — | 1,500,000USD |
| Accounts Payable | 4,587,000USD | 319,000USD | 129,000USD | 2,501,000USD | 567,000USD | 1,158,000USD | 421,000USD | 121,000USD |
| Property Plant Equipment Net | 2,007,000USD | 3,252,000USD | 4,437,000USD | 5,316,000USD | 5,217,000USD | 3,585,000USD | — | — |
| Property Plant Equipment Gross | 6,274,000USD | 6,547,000USD | 6,771,000USD | 6,684,000USD | 5,740,000USD | — | — | — |
| Accumulated Other Comprehensive Income | -4,000USD | 1,000USD | -349,000USD | -1,956,000USD | -388,000USD | 33,000USD | — | -17,054,000USD |
| Common Stock Shares Outstanding | 4,275,762shares | 3,848,088shares | 3,802,018shares | 3,773,324shares | 3,692,117shares | 3,248,578shares | 3,261,932shares | 3,261,932shares |
| Non Current Assets Total | 2,693,000USD | 3,938,000USD | 5,516,000USD | 50,620,000USD | 71,209,000USD | 87,226,000USD | 29,000USD | 36,000USD |
| Non Current Liabilities Total | 16,858,000USD | 803,000USD | 1,217,000USD | 1,585,000USD | 1,632,000USD | 876,000USD | 20,639,000USD | 19,248,000USD |
| Non Current Liabilities Other | 16,520,000USD | — | — | — | — | — | — | — |
| Non Currrent Assets Other | 686,000USD | 55,000USD | 448,000USD | 475,000USD | 56,000USD | 132,000USD | 29,000USD | — |
| Net Working Capital | 41,955,000USD | 41,706,000USD | 125,889,000USD | 186,102,000USD | 251,507,000USD | — | — | — |
| Unclassified Equity | 539,547,000USD | 450,978,000USD | 439,735,000USD | 428,619,000USD | 417,359,000USD | 315,288,000USD | 1,364,000USD | 18,090,000USD |
| Long Term Investments | — | — | 0USD | 44,829,000USD | 65,936,000USD | — | — | — |
| Net Receivables | — | — | 1,628,000USD | 1,227,000USD | 2,336,000USD | 1,300,000USD | 7,000USD | 6,000USD |
| Unclassified Non Current Liabilities | — | — | 1,217,000USD | 1,585,000USD | 1,632,000USD | — | 20,639,000USD | 19,248,000USD |
| Inventory | — | — | — | -1,227,000USD | — | — | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | 83,509,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 458,000USD |
| Stock Based Compensation | 3,843,000USD |
| Change To Liabilities | -2,594,000USD |
| Change In Working Capital | -4,838,000USD |
| Operating Cash Flow | -37,861,000USD |
| Net Investments | 794,000USD |
| Investing Cash Flow | 794,000USD |
| Financing Cash Flow | 114,000USD |
| Change In Cash | -36,953,000USD |
| End Cash Flow | 32,954,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -32,948,000USD | -82,889,000USD | -6,611,000USD | -6,966,000USD | -9,143,000USD | -15,003,000USD | -28,741,000USD | -26,859,000USD |
| Depreciation | -29,000USD | 241,000USD | 243,000USD | 116,000USD | 243,000USD | 243,000USD | -245,000USD | 242,000USD |
| Stock Based Compensation | 662,000USD | 1,458,000USD | 1,410,000USD | 1,597,000USD | 1,637,000USD | 2,229,000USD | 2,936,000USD | 3,205,000USD |
| Other Non Cash Items | 15,465,000USD | 71,008,000USD | -1,000USD | 67,000USD | 1,637,000USD | 36,000USD | 493,000USD | -106,000USD |
| Change In Working Capital | -4,053,000USD | -9,215,000USD | 291,000USD | -1,813,000USD | -7,402,000USD | -13,518,000USD | 2,534,000USD | 1,188,000USD |
| Total Cash From Operating Activities | -20,903,000USD | -19,397,000USD | -4,668,000USD | -6,999,000USD | -14,665,000USD | -26,013,000USD | -23,023,000USD | -22,330,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -28,000USD |
| Free Cash Flow | -20,903,000USD | -19,397,000USD | -4,668,000USD | -6,999,000USD | -14,665,000USD | -26,013,000USD | -23,023,000USD | -22,358,000USD |
| Investments | -15,540,000USD | -14,638,000USD | 5,654,000USD | 441,000USD | -7,351,000USD | -2,812,000USD | 18,039,000USD | — |
| Total Cashflows From Investing Activities | -15,540,000USD | -14,638,000USD | 5,654,000USD | 441,000USD | -7,351,000USD | -2,812,000USD | 18,039,000USD | 26,562,000USD |
| Change In Cash | -36,443,000USD | 48,402,000USD | 986,000USD | -6,534,000USD | -22,016,000USD | -28,791,000USD | -4,972,000USD | 4,380,000USD |
| Begin Period Cash Flow | 69,907,000USD | 21,505,000USD | 19,888,000USD | 27,053,000USD | 49,069,000USD | 77,860,000USD | 82,832,000USD | 77,821,000USD |
| End Period Cash Flow | 33,464,000USD | 69,907,000USD | 20,874,000USD | 20,519,000USD | 27,053,000USD | 49,069,000USD | 77,860,000USD | 82,201,000USD |
| Total Cash From Financing Activities | — | 82,437,000USD | 0USD | 24,000USD | — | 34,000USD | 12,000USD | 148,000USD |
| Sale Purchase Of Stock | — | -24,000USD | — | 24,000USD | — | — | — | — |
| Other Cashflows From Financing Activities | — | 82,437,000USD | — | — | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | -1,637,000USD | — | — | — |
| Change To Account Receivables | — | — | — | — | — | 1,628,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | 26,590,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -105,609,000USD | -96,940,000USD | -117,672,000USD | -95,639,000USD | -54,853,000USD | -19,955,000USD | -5,161,000USD | -5,097,000USD |
| Depreciation | 643,000USD | 455,000USD | 969,000USD | 1,048,000USD | 479,000USD | 251,000USD | — | — |
| Stock Based Compensation | 6,102,000USD | 11,049,000USD | 10,623,000USD | 10,606,000USD | 4,623,000USD | 633,000USD | 253,000USD | 196,000USD |
| Other Non Cash Items | 53,135,000USD | 248,000USD | -1,200,000USD | 10,184,000USD | 648,000USD | 1,654,000USD | 517,000USD | 173,000USD |
| Change In Working Capital | -19,376,000USD | -11,982,000USD | 6,527,000USD | 11,938,000USD | 6,005,000USD | -6,445,000USD | 678,000USD | 245,000USD |
| Total Cash From Operating Activities | -45,729,000USD | -97,170,000USD | -100,753,000USD | -72,469,000USD | -43,098,000USD | -24,113,000USD | -3,713,000USD | -4,483,000USD |
| Capital Expenditures | 0USD | -33,000USD | -304,000USD | -1,141,000USD | -1,573,000USD | -2,320,000USD | 0USD | 0USD |
| Free Cash Flow | -45,729,000USD | -97,203,000USD | -101,057,000USD | -73,610,000USD | -44,671,000USD | -26,433,000USD | -3,713,000USD | -4,483,000USD |
| Investments | -15,894,000USD | 54,863,000USD | 95,393,000USD | 58,805,000USD | -2,506,000USD | — | — | — |
| Total Cashflows From Investing Activities | -15,894,000USD | 54,830,000USD | 95,089,000USD | 57,664,000USD | -4,079,000USD | -210,068,000USD | 1,506,000USD | 2,007,000USD |
| Total Cash From Financing Activities | 82,461,000USD | 194,000USD | 493,000USD | 654,000USD | 97,089,000USD | 292,750,000USD | 946,000USD | 1,464,000USD |
| Change In Cash | 20,838,000USD | -42,146,000USD | -5,171,000USD | -14,571,000USD | 49,912,000USD | 58,569,000USD | -1,261,000USD | -1,012,000USD |
| Begin Period Cash Flow | 49,069,000USD | 91,215,000USD | 96,386,000USD | 110,537,000USD | 60,625,000USD | 2,056,000USD | 3,317,000USD | 4,329,000USD |
| End Period Cash Flow | 69,907,000USD | 49,069,000USD | 91,215,000USD | 95,966,000USD | 110,537,000USD | 60,625,000USD | 2,056,000USD | 3,317,000USD |
| Other Cashflows From Financing Activities | 82,461,000USD | — | — | — | 327,000USD | 82,569,000USD | — | 198,000USD |
| Unclassified Operating Cash Flow | 19,376,000USD | — | — | -10,606,000USD | — | — | — | — |
| Change To Account Receivables | — | 1,628,000USD | -401,000USD | 1,109,000USD | -1,036,000USD | -1,300USD | — | — |
| Issuance Of Capital Stock | — | — | — | 0USD | 96,762,000USD | — | — | — |
| Net Borrowings | — | — | — | — | 0USD | — | — | — |
| Change To Inventory | — | — | — | — | — | 1,300USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 36,000USD | 6,000USD | 7,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | -207,784,000USD | 1,500,000USD | 2,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 210,181,000USD | — | 1,266,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.